Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
NCT01382225
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1936
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndrome
Interventions
DRUG:
Sodium Hyaluronate Ophthalmic Solution, 0.18%
OTHER:
Vehicle
Sponsor
Alcon Research